In the future, we will consider designing our study to document more confounding factors, including ALT and AST fluctuations, cytolytic activity, NAFLD, viral hepatitis, alcohol abuse, and use of drugs during follow-up. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.